Cullinan Therapeutics Inc (CGEM)
SG&A Expense Growth
10.74%
Quarterly · Period ending:
CGEM SG&A Expense Growth
Latest reported10.74%period ending
Latest reported10.74%period ending
CGEM Quarterly SG&A Growth (QoQ) (0.00% → 10.74%)
Latest values, visible window
High-resolution chart · PNG
CGEM sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 10.7396% | |
| -6.0094% | |
| -9.6353% | |
| -7.7262% | |
| 9.0936% | |
| -7.0005% | |
| 9.0419% | |
| -2.498% | |
| 11.6084% | |
| 16.1648% | |
| -3.8427% | |
| 7.5191% | |
| -4.1839% | |
| -5.5551% | |
| 11.9076% | |
| -5.6942% | |
| 31.6956% | |
| -39.706% | |
| 136.5057% | |
| 18.0066% | |
| -6.4003% | |
| -58.8967% | |
| 690.9206% | |
| -2.46% | |
| 18.8596% | |
| 16.2277% | |
| -29.8151% | |
| 27.6256% | |
| 0% | |
| 0% |